Innate Pharma SA (IPHA)
1.62
-0.07
(-4.14%)
USD |
NASDAQ |
Feb 20, 16:00
1.73
+0.11
(+6.79%)
After-Hours: 20:00
Innate Pharma Market Cap : 151.83M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nicox SA | 24.28M |
| DBV Technologies SA | 1.179B |
| Cellectis SA | 392.30M |
| Genfit SA | 462.84M |
| Transgene SA | 132.29M |
Market Cap Related Metrics
| PS Ratio | 20.92 |
| Price | 1.62 |
| Earnings Yield | -36.87% |